Long and short noncoding RNAs in lung cancer precision medicine: Opportunities and challenges
The long and short noncoding RNAs have been involved in the molecular diagnosis, targeted therapy, and predicting prognosis of lung cancer. Utilizing noncoding RNAs as biomarkers and systemic RNA interference as an innovative therapeutic strategy has an immense likelihood to generate novel concepts...
Saved in:
| Main Authors: | Haihua Tian, Chengwei Zhou, Jie Yang, Jingqiu Li, Zhaohui Gong |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2017-04-01
|
| Series: | Tumor Biology |
| Online Access: | https://doi.org/10.1177/1010428317697578 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Long noncoding RNAs in familial hypercholesterolemia: biomarkers, therapeutics, and AI in precision medicine
by: Hussam Daghistani, et al.
Published: (2025-05-01) -
Exploring the role of noncoding RNAs in cancer diagnosis, prognosis, and precision medicine
by: Basmah Eldakhakhny, et al.
Published: (2024-12-01) -
Long noncoding RNAs in renal diseases
by: Minghui Liu, et al.
Published: (2019-12-01) -
Biomolecules Interacting with Long Noncoding RNAs
by: Hidenori Tani
Published: (2025-04-01) -
Influence of migrasome-associated long noncoding RNAs on the immune microenvironment and prognosis in lung adenocarcinoma
by: Hui Zhao, et al.
Published: (2025-06-01)